MedPath
HSA Approval

VALGANCICLOVIR SANDOZ FILM COATED TABLET 450MG

SIN15985P

VALGANCICLOVIR SANDOZ FILM COATED TABLET 450MG

VALGANCICLOVIR SANDOZ FILM COATED TABLET 450MG

August 7, 2020

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J05AB14

valganciclovir

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Bluepharma - Indústria Farmacêutica, S.A.

Active Ingredients

Valganciclovir hydrochloride eqv Valganciclovir

450mg

Valganciclovir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VALGANCICLOVIR SANDOZ FILM COATED TABLET 450MG - HSA Approval | MedPath